NYSE:AVNS (USA) Also trade in: Germany

Avanos Medical Inc

$ 43.02 0 (0%)
Volume: 280,791 Avg Vol (1m): 371,214
Market Cap $: 2.04 Bil Enterprise Value $: 1.94 Bil
P/E (TTM): 0.00 P/B: 1.60
Earnings Power Value 8.42
Net Current Asset Value 2.23
Tangible Book 7.02
Projected FCF 30.79
Median P/S Value 44.61
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 6/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 1.41
Cash-To-Debt ranked lower than
75.61% of 205 companies
in the Medical Instruments & Supplies industry.
Industry Max: 10000, Med: 1.74, Min: 0.01
AVNS: 1.41
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.13, Med: 0.29, Max: 5.36
Current: 1.41
0.13
5.36
Equity-to-Asset 0.70
Equity-to-Asset ranked lower than
60.71% of 196 companies
in the Medical Instruments & Supplies industry.
Industry Max: 2.26, Med: 0.6, Min: -5.6
AVNS: 0.7
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.52, Med: 0.58, Max: 0.85
Current: 0.7
0.52
0.85
Debt-to-Equity 0.19
Debt-to-Equity ranked lower than
62.68% of 142 companies
in the Medical Instruments & Supplies industry.
Industry Max: 3.57, Med: 0.37, Min: 0.01
AVNS: 0.19
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.42, Max: 0.57
Current: 0.19
0
0.57
Debt-to-EBITDA 9.46
Debt-to-EBITDA ranked lower than
97.25% of 109 companies
in the Medical Instruments & Supplies industry.
Industry Max: 66.68, Med: 1.88, Min: 0.02
AVNS: 9.46
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: -14.02, Med: 0.26, Max: 30.74
Current: 9.46
-14.02
30.74
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.72
DISTRESS
GREY
SAFE
Beneish M-Score -1.94
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -0.84%
WACC 8.3%

Profitability & Growth : 3/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -2.59
Operating Margin ranked lower than
66.67% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 239.27, Med: 4.41, Min: -219137.5
AVNS: -2.59
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -26.66, Med: 2.86, Max: 13.54
Current: -2.59
-26.66
13.54
Net Margin % 2.58
Net Margin ranked higher than
77.61% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 182.67, Med: 4.18, Min: -221450
AVNS: 2.58
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -83.75, Med: 8.7, Max: 12.97
Current: 2.58
-83.75
12.97
ROE % 1.32
ROE ranked higher than
54.04% of 198 companies
in the Medical Instruments & Supplies industry.
Industry Max: 95.67, Med: 5.43, Min: -1452.51
AVNS: 1.32
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -33.48, Med: 4.58, Max: 14.85
Current: 1.32
-33.48
14.85
ROA % 0.88
ROA ranked higher than
54.85% of 206 companies
in the Medical Instruments & Supplies industry.
Industry Max: 46.82, Med: 1.85, Min: -307.58
AVNS: 0.88
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -18.87, Med: 2.85, Max: 12.04
Current: 0.88
-18.87
12.04
ROC (Joel Greenblatt) % -2.58
ROC (Joel Greenblatt) ranked lower than
65.20% of 204 companies
in the Medical Instruments & Supplies industry.
Industry Max: 387.24, Med: 9.63, Min: -114200
AVNS: -2.58
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -27.89, Med: 1.8, Max: 78.4
Current: -2.58
-27.89
78.4
3-Year Total Revenue Growth Rate 8.60
3-Year Revenue Growth Rate ranked lower than
92.94% of 170 companies
in the Medical Instruments & Supplies industry.
Industry Max: 1424.9, Med: 4.1, Min: -100
AVNS: 8.2
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -32.9, Med: -28.6, Max: 8.2
Current: 8.2
-32.9
8.2
3-Year EPS w/o NRI Growth Rate 56.40
3-Year EPS w/o NRI Growth Rate ranked lower than
100.00% of 155 companies
in the Medical Instruments & Supplies industry.
Industry Max: 253, Med: 12.9, Min: -782.7
AVNS: 56.4
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 56.4
Current: 56.4
0
56.4

» AVNS's 30-Y Financials

Financials (Next Earnings Date: 2019-08-07)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:AVNS

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS : 339113    SIC : 3842
Compare NAS:MMSI TSE:7732 SZSE:002901 NAS:NVCR XTER:GXI NAS:NXTM FRA:PHH2 ASX:ANN ROCO:1565 NAS:IRTC SZSE:002414 SZSE:300061 XKLS:7153 OSTO:GETI B TSE:3593 TSE:7730 NAS:ATRI SZSE:300595 SZSE:300677 NYSE:GKOS
Traded in other countries 8HH.Germany
Address 5405 Windward Parkway, Suite 100 South, Alpharetta, GA, USA, 30004
Halyard Health Inc sells products and solutions used to prevent infections, reduce pain, and improve recovery. The firm operates in two segments based on products: Surgical & Infection Prevention and Medical Devices. The S&IP segment contributes the largest proportion of revenue. It provides healthcare supplies used to prevent infections, including sterilization wraps, surgical gowns, facial protection, and medical-exam gloves. The Medical Devices segment sells products related to pain management and respiratory and digestive health, such as interventional pain therapies, closed airway suction systems, and feeding tubes. Halyard Health generates the majority of its revenue in North America.

Ratios

Current vs industry vs history
PE Ratio (TTM) 126.52
PE Ratio ranked higher than
60.00% of 125 companies
in the Medical Instruments & Supplies industry.
Industry Max: 1012.86, Med: 31.7, Min: 0.65
AVNS: 126.52
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 24.36, Med: 39.46, Max: 140.85
Current: 126.52
24.36
140.85
PB Ratio 1.60
PB Ratio ranked higher than
70.98% of 193 companies
in the Medical Instruments & Supplies industry.
Industry Max: 53.91, Med: 3.45, Min: 0.13
AVNS: 1.6
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0.94, Med: 1.56, Max: 2.66
Current: 1.6
0.94
2.66
PS Ratio 3.09
PS Ratio ranked lower than
54.69% of 192 companies
in the Medical Instruments & Supplies industry.
Industry Max: 720.69, Med: 3.48, Min: 0.08
AVNS: 3.09
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.82, Med: 3.24, Max: 31.26
Current: 3.09
0.82
31.26
EV-to-EBIT -245.97
EV-to-EBIT ranked lower than
100.00% of 121 companies
in the Medical Instruments & Supplies industry.
Industry Max: 126.36, Med: 23.93, Min: 0.21
AVNS: -245.97
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -478.3, Med: -12.6, Max: 276.1
Current: -245.97
-478.3
276.1
EV-to-EBITDA 74.13
EV-to-EBITDA ranked lower than
97.10% of 138 companies
in the Medical Instruments & Supplies industry.
Industry Max: 614.98, Med: 19.49, Min: 0.2
AVNS: 74.13
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -58, Med: 5.6, Max: 142.2
Current: 74.13
-58
142.2
EV-to-Revenue 2.92
EV-to-Revenue ranked lower than
57.29% of 199 companies
in the Medical Instruments & Supplies industry.
Industry Max: 4881, Med: 3.57, Min: 0.12
AVNS: 2.92
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 1.1, Med: 4, Max: 34.6
Current: 2.92
1.1
34.6
Current Ratio 2.77
Current Ratio ranked higher than
59.50% of 200 companies
in the Medical Instruments & Supplies industry.
Industry Max: 30.7, Med: 2.57, Min: 0.1
AVNS: 2.77
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 1.65, Med: 2.11, Max: 3.22
Current: 2.77
1.65
3.22
Quick Ratio 2.22
Quick Ratio ranked higher than
68.16% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 30.69, Med: 1.87, Min: -1.52
AVNS: 2.22
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.81, Med: 1.13, Max: 2.96
Current: 2.22
0.81
2.96
Days Inventory 159.76
Days Inventory ranked lower than
84.26% of 197 companies
in the Medical Instruments & Supplies industry.
Industry Max: 876.25, Med: 124.35, Min: 0.86
AVNS: 159.76
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 50.91, Med: 114.14, Max: 425.95
Current: 159.76
50.91
425.95
Days Sales Outstanding 74.65
Days Sales Outstanding ranked lower than
87.88% of 165 companies
in the Medical Instruments & Supplies industry.
Industry Max: 655.77, Med: 61.97, Min: 1
AVNS: 74.65
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 39.82, Med: 84.21, Max: 161.13
Current: 74.65
39.82
161.13
Days Payable 207.69
Days Payable ranked higher than
93.38% of 151 companies
in the Medical Instruments & Supplies industry.
Industry Max: 713.41, Med: 54.66, Min: 2
AVNS: 207.69
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 34.49, Med: 217.91, Max: 237.24
Current: 207.69
34.49
237.24

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -0.40
3-Year Share Buyback Rate ranked higher than
76.22% of 143 companies
in the Medical Instruments & Supplies industry.
Industry Max: 9.1, Med: -5, Min: -273.3
AVNS: -0.4
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -0.4, Med: -0.1, Max: 0
Current: -0.4
-0.4
0

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 6.13
Price-to-Tangible-Book ranked lower than
67.07% of 167 companies
in the Medical Instruments & Supplies industry.
Industry Max: 3100, Med: 4.77, Min: 0.22
AVNS: 6.13
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 6.08, Med: 9.57, Max: 525.97
Current: 6.13
6.08
525.97
Price-to-Projected-FCF 1.40
Price-to-Intrinsic-Value-Projected-FCF ranked lower than
100.00% of 75 companies
in the Medical Instruments & Supplies industry.
Industry Max: 161.65, Med: 2.41, Min: 0.16
AVNS: 1.4
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 1.35, Med: 1.5, Max: 2.06
Current: 1.4
1.35
2.06
Price-to-Median-PS-Value 0.96
Price-to-Median-PS-Value ranked lower than
56.25% of 160 companies
in the Medical Instruments & Supplies industry.
Industry Max: 4.9, Med: 1.13, Min: 0.01
AVNS: 0.96
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.26, Med: 0.96, Max: 8.05
Current: 0.96
0.26
8.05
Earnings Yield (Joel Greenblatt) % -0.41
Earnings Yield (Greenblatt) ranked lower than
66.67% of 207 companies
in the Medical Instruments & Supplies industry.
Industry Max: 476.19, Med: 2.4, Min: -3333.33
AVNS: -0.41
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -20.8, Med: -1.5, Max: 16.6
Current: -0.41
-20.8
16.6

More Statistics

Revenue (TTM) (Mil) $ 660.1
EPS (TTM) $ 0.34
Beta 1.15
Volatility % 45.95
52-Week Range $ 38 - 72.96
Shares Outstanding (Mil) 47.5

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 4
Positive ROA Y
Positive CFROA N
Higher ROA yoy N
CFROA > ROA N
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y